Cipla gains despite its arm receives two inspectional observations from USFDA

Mumbai, February 11 (Udaipur Kiran): Cipla is currently trading at Rs. 1347.65, up by 5.55 points or 0.41% from its previous closing of Rs. 1342.10 on the BSE. The scrip opened at Rs. 1348.20 and has touched a high and low of Rs. 1350.00 and Rs. 1335.00 respectively. So far 29185 shares were traded on […]

Read More

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs […]

Read More